Beijing three antibody drugs enter clinical trials to fill the domestic blank
Release time: 2010-07-21 & nbsp & nbsp & nbsp Source:
"Among the three antibody drugs we developed，One stake online sports bettingof them has entered the clinical experimental stage。"Yesterday，Director of the Cancer Center of the General Hospital of the PLA told reporters。He said to reporters，Since antibody drugs are a special effect drug，The threshold is higher，The industry generally believes that the highest state of biological engineering pharmaceuticals is the development of antibody drugs。
The reporter learned from the Municipal Science and Technology Commission，Beijing's key laboratory of antibody drugs is a major science and technology project supported by the Municipal Science and Technology Commission，The project relies on the Cancer Center of the General Hospital of the People's Liberation Army，With Guo Yajun's scientific research team as the main body，Focus on research and development of "Anti -CD20 humanized single cloning antibody"、"SM5-1 dual-function antibody"Stake Sports Betting、"Anti -EGFR humanized single cloning antibody" and other three national categories Ⅰ innovative drugs，It will treat non -Hodgkin lymphoma、Breast cancer、Liver cancer and colorectal cancer provide effective treatment drugs。
Current，The three antibody drugs developed by the laboratory are all new antibody drugs，There are no similar products in China，Once the development is successful，Category Ⅰ innovative drugs for independent intellectual property rights，The speed of research and development and industrialization of Beijing antibody drugs will be greatly promoted，Quickly improve the research and development ability of Beijing antibody drugs。
The reporter learned，antibody technology is one of the most important scientific achievements in the twentieth century and one of the most important science and technology stake betting appforefronts，Antibody drugs as special effects treatment methods for many diseases that seriously endanger human health，is the field of high importance to development in the world。Current，26 antibody drugs on the world，More than 700 antibody drugs in R & D。In the past 7 years，Its global sales rose from $ 1.7 billion to $ 36 billion，The proportion of global biological products also increased from 8.5%to 34.95%，The contribution to the growth of global biological products has reached 47%。
The reporter learned from the Municipal Science and Technology Commission，Beijing's key laboratory of antibody drugs is a major science and technology project supported by the Municipal Science and Technology Commission，The project relies on the Cancer Center of the General Hospital of the People's Liberation Army，With Guo Yajun's scientific research team as the main body，Focus on research and development of "Anti -CD20 humanized single cloning antibody"、"SM5-1 dual-function antibody"Stake Sports Betting、"Anti -EGFR humanized single cloning antibody" and other three national categories Ⅰ innovative drugs，It will treat non -Hodgkin lymphoma、Breast cancer、Liver cancer and colorectal cancer provide effective treatment drugs。
Current，The three antibody drugs developed by the laboratory are all new antibody drugs，There are no similar products in China，Once the development is successful，Category Ⅰ innovative drugs for independent intellectual property rights，The speed of research and development and industrialization of Beijing antibody drugs will be greatly promoted，Quickly improve the research and development ability of Beijing antibody drugs。
The reporter learned，antibody technology is one of the most important scientific achievements in the twentieth century and one of the most important science and technology stake betting appforefronts，Antibody drugs as special effects treatment methods for many diseases that seriously endanger human health，is the field of high importance to development in the world。Current，26 antibody drugs on the world，More than 700 antibody drugs in R & D。In the past 7 years，Its global sales rose from $ 1.7 billion to $ 36 billion，The proportion of global biological products also increased from 8.5%to 34.95%，The contribution to the growth of global biological products has reached 47%。
